Last reviewed · How we verify
NCT06740760: AuGeS-GV
Autism Genomics Sweden - Genetic Guidance and Information Trial
NA trial testing Genetic counselling in Autism in 63 participants. Completed in 31 July 2025.
30 June 2025
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 63 |
| Start date | 15 June 2024 |
| Primary completion | 30 June 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Genetic counselling
- Leaflet
Conditions studied
- Autism — all drugs for Autism →
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- ADHD - Attention Deficit Disorder With Hyperactivity — all drugs for ADHD - Attention Deficit Disorder With Hyperactivity →
- Depression Anxiety Disorder — all drugs for Depression Anxiety Disorder →
Sponsor
Karolinska Institutet
Who can join
Adults 15 to 30, any sex, with Autism or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational clinical trial aims to evaluate whether providing genetic information about the origins of autism and related psychiatric disorders enhances understanding, well-being, and empowerment in adolescents and young adults with autism. The study will compare the outcomes of two groups: one receiving a 1.5-hour genetic counseling session with a clinician and the other receiving general genetic information via a leaflet. Participants will be assessed using pre- and post-intervention questionnaires, including measures of understanding of their condition (mGCOS-24) and mental health (GAD-7 and PHQ-9). The study also explores whether mental health factors like anxiety and depression influence the effectiveness of the interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06740760
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Genetic counselling
Trials testing the same drug.
- NCT03601026 — Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use · NA · recruiting
Other recruiting trials for Autism
Currently open trials in the same condition.
- NCT07367256 — Using Virtual Reality to Improve Emotion Understanding in Children With Autism · NA · recruiting
- NCT06853665 — The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine · Phase 4 · recruiting
- NCT06523387 — Online Pivotal Response Treatment Training in Autism Spectrum Disorder · NA · recruiting
- NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
- NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06740760 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06740760.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing